IL-4 was demonstrated to negatively regulate the anti-tumor function of γδT cells via inhibiting the expression of NKG2D and promoting the IL-10 production from Vδ1 cells, which in turn suppressed IFN-γ production and the proliferation of Vδ2 cells (91). The gene discussed is IFNG; the disease is neoplasm.